Tristetraprolin expression and microRNA-mediated regulation during simian immunodeficiency virus infection of the central nervous system

Molecular Brain

Volumn 6, Issue 1, 2013, Pages

  Liu, Jonathan ^a   Sisk, Jeanne M ^a   Gama, Lucio ^a   Clements, Janice E ^a   Witwer, Kenneth W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; HIV associated neurocognitive disorder; Human immunodeficiency virus; microRNA; RNA binding protein; Tristetraprolin

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 145; MICRORNA 29A; TRISTETRAPROLIN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CELL STRAIN HEK293; CENTRAL NERVOUS SYSTEM INFECTION; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; MACACA NEMESTRINA; MACROPHAGE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; RETROVIRUS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME;

HUMAN IMMUNODEFICIENCY VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CENTRAL NERVOUS SYSTEM; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; MACACA; MACROPHAGES; MICRORNAS; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; THALAMUS; TRANSFECTION; TRISTETRAPROLIN;

EID: 84883144930     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-6-40     Document Type: Article

References (65)

1. The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic. Broder S, Antiviral Res 2010 85 1 18 10.1016/j.antiviral. 2009.10.002 20018391
2. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, Schiffer V, Calmy A, Chave JP, Giacobini E, Hirschel B, Du Pasquier RA, AIDS 2010 24 1243 1250 19996937
3. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. Cysique LA, Maruff P, Brew BJ, J Neurovirol 2004 10 350 357 10.1080/13550280490521078 15765806 (Pubitemid 40109622)
4. Updated research nosology for HIV-associated neurocognitive disorders. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE, Neurology 2007 69 1789 1799 10.1212/01.WNL.0000287431. 88658.8b 17914061 (Pubitemid 350059308)
5. Neurologic complications of HIV disease and their treatment. Letendre SL, Ellis RJ, Ances BM, McCutchan JA, Top HIV Med 2010 18 45 55 20516524
6. Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap. McArthur JC, Steiner J, Sacktor N, Nath A, Ann Neurol 2010 67 699 714 20517932
7. Role of Tat protein in HIV neuropathogenesis. Li W, Li G, Steiner J, Nath A, Neurotox Res 2009 16 205 220 10.1007/s12640-009-9047-8 19526283
8. HIV-1 gp120 and Drugs of Abuse: Interactions in the Central Nervous System. Silverstein PS, Shah A, Weemhoff J, Kumar S, Singh DP, Kumar A, Curr HIV Res 2012 10 369 383 10.2174/157016212802138724 22591361
9. Associations of cytokines, sleep patterns, and neurocognitive function in youth with HIV infection. Foster SB, Lu M, Glaze DG, Reuben JM, Harris LL, Cohen EN, Lee BN, Zhao E, Paul ME, Schwarzwald H, McMullen-Jackson C, Clark C, Armstrong FD, Brouwers PY, Miller TL, Colin AA, Scott GB, Shahzeidi S, Willen EJ, Asthana D, Lipshultz SE, Thompson BW, Shearer WT, Clin Immunol 2012 144 13 23 10.1016/j.clim.2012.04.004 22659030
10. Cytokine levels in CSF and neuropsychological performance in HIV patients. Nolting T, Lindecke A, Hartung HP, Koutsilieri E, Maschke M, Husstedt IW, Sopper S, Stuve O, Arendt G, J Neurovirol 2012 18 157 161 10.1007/s13365-012-0091-4 22528475
11. Biomarkers of neurological status in HIV infection: a 3-year study. Ragin AB, Wu Y, Ochs R, Scheidegger R, Cohen BA, Edelman RR, Epstein LG, McArthur J, Proteomics Clin Appl 2010 4 295 303 10.1002/prca.200900083 21137050
12. Coordinated regulation of SIV replication and immune responses in the CNS. Witwer KW, Gama L, Li M, Bartizal CM, Queen SE, Varrone JJ, Brice AK, Graham DR, Tarwater PM, Mankowski JL, Zink MC, Clements JE, PLoS One 2009 4 8129 10.1371/journal.pone.0008129 20019816
13. A plasma microRNA signature of acute lentiviral infection: biomarkers of CNS disease. Witwer KW, Sarbanes SL, Liu J, Clements JE, AIDS 2011 204 1104 1114
14. High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. Zink MC, Suryanarayana K, Mankowski JL, Shen A, Piatak M Jr, Spelman JP, Carter DL, Adams RJ, Lifson JD, Clements JE, J Virol 1999 73 10480 10488 10559366
15. A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system. Clements JE, Gama L, Graham DR, Mankowski JL, Zink MC, Curr Opin HIV AIDS 2011 6 37 42 10.1097/COH.0b013e3283412413 21242892
16. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. Goddio MV, Gattelli A, Slomiansky V, Lacunza E, Gingerich T, Tocci JM, Facchinetti MM, Curino AC, Lamarre J, Abba MC, Kordon EC, Breast Canc Res Treat 2012 135 749 758 10.1007/s10549-012-2216-0
17. Comparative functional analysis of ZFP36 genes during Xenopus development. Treguer K, Faucheux C, Veschambre P, Fedou S, Theze N, Thiebaud P, PLoS One 2013 8 54550 10.1371/journal.pone.0054550 23342169
18. The role of tristetraprolin in cancer and inflammation. Sanduja S, Blanco FF, Young LE, Kaza V, Dixon DA, Front Biosci 2012 17 174 188 10.2741/3920
19. Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence. Abdelmohsen K, Kuwano Y, Kim HH, Gorospe M, Biol Chem 2008 389 243 255 18177264 (Pubitemid 351329020)
20. Zinc finger protein tristetraprolin interacts with CCL3 mRNA and regulates tissue inflammation. Kang JG, Amar MJ, Remaley AT, Kwon J, Blackshear PJ, Wang PY, Hwang PM, J Immunol 2011 187 2696 2701 10.4049/jimmunol.1101149 21784977
21. Tristetraprolin regulates IL-8 mRNA stability in cystic fibrosis lung epithelial cells. Balakathiresan NS, Bhattacharyya S, Gutti U, Long RP, Jozwik C, Huang W, Srivastava M, Pollard HB, Biswas R, Am J Physiol Lung Cell Mol Physiol 2009 296 1012 L1018 10.1152/ajplung.90601.2008 19363120
22. Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements. Khabar KS, Cell Mol Life Sci 2010 67 2937 2955 10.1007/s00018-010-0383-x 20495997
23. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. Gebeshuber CA, Zatloukal K, Martinez J, EMBO Rep 2009 10 400 405 10.1038/embor.2009.9 19247375
24. miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer. Al-Ahmadi W, Al-Ghamdi M, Al-Souhibani N, Khabar KS, J Pathol 2013 230 28 38 10.1002/path.4178 23401122
25. MicroRNAs in Stress Signaling and Human Disease. Mendell JT, Olson EN, Cell 2012 148 1172 1187 10.1016/j.cell.2012.02.005 22424228
26. MicroRNAs: target recognition and regulatory functions. Bartel DP, Cell 2009 136 215 233 10.1016/j.cell.2009.01.002 19167326
27. SIV Replication is Directly Downregulated by Four Antiviral miRNAs. Sisk JM, Witwer KW, Tarwater PM, Clements JE, Retrovirology 2013 Accepted
28. miRNAs and HIV: unforeseen determinants of host-pathogen interaction. Swaminathan S, Murray DD, Kelleher AD, Immunol Rev 2013 254 265 280 10.1111/imr.12077 23772625
29. Altered microRNA expression profile in amyotrophic lateral sclerosis: a role in the regulation of NFL mRNA levels. Campos-Melo D, Droppelmann CA, He Z, Volkening K, Strong MJ, Mol Brain 2013 6 26 10.1186/1756-6606-6-26 23705811
30. Modulation of BK Channel by MicroRNA-9 in Neurons After Exposure to HIV and Methamphetamine. Tatro ET, Hefler S, Shumaker-Armstrong S, Soontornniyomkij B, Yang M, Yermanos A, Wren N, Moore DJ, Achim CL, J Neuroimmune Pharmacol 2013 27 3720 3729
31. Translating the brain transcriptome in neuroAIDS: from non-human primates to humans. Winkler JM, Chaudhuri AD, Fox HS, J Neuroimmune Pharmacol 2012 7 372 379 10.1007/s11481-012-9344-5 22367717
32. Up-regulation of microRNA-142 in simian immunodeficiency virus encephalitis leads to repression of sirtuin1. Chaudhuri AD, Yelamanchili SV, Marcondes MC, Fox HS, Faseb J 2013 http://www.fasebj.org/content/27/9/3720.full
33. Multiple functions of tristetraprolin/TIS11 RNA-binding proteins in the regulation of mRNA biogenesis and degradation. Ciais D, Cherradi N, Feige JJ, Cell Mol Life Sci 2012 70 2031 2044 22968342
34. Expression of TNF-alpha, tristetraprolin, T-cell intracellular antigen-1 and Hu antigen R genes in synovium of patients with rheumatoid arthritis. Suzuki E, Tsutsumi A, Sugihara M, Mamura M, Goto D, Matsumoto I, Ito S, Ikeda K, Ochiai N, Sato Y, Sumida T, Int J Mol Med 2006 18 273 278 16820934
35. Multiple tristetraprolin sequence domains required to induce apoptosis and modulate responses to TNFalpha through distinct pathways. Johnson BA, Blackwell TK, Oncogene 2002 21 4237 4246 10.1038/sj.onc.1205526 12082611 (Pubitemid 34753830)
36. MAPKAP kinases MK2 and MK3 in inflammation: complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin. Ronkina N, Menon MB, Schwermann J, Tiedje C, Hitti E, Kotlyarov A, Gaestel M, Biochem Pharmacol 2010 80 1915 1920 10.1016/j.bcp.2010.06.021 20599781
37. miRNA Profiles of Monocyte-Lineage Cells Are Consistent with Complicated Roles in HIV-1 Restriction. Sisk JM, Clements JE, Witwer KW, Viruses 2012 4 1844 1864 10.3390/v4101844 23202444
38. Sisk JM KWW, Clements JE, in CROI 2012 (Conference on Retroviruses and Opportunistic Infections) (Seattle, WA) 2012
39. miR-451 regulates dendritic cell cytokine responses to influenza infection. Rosenberger CM, Podyminogin RL, Navarro G, Zhao GW, Askovich PS, Weiss MJ, Aderem A, J Immunol 2012 189 5965 5975 10.4049/jimmunol.1201437 23169590
40. Regulation of miR-155 biogenesis in cystic fibrosis lung epithelial cells: antagonistic role of two mRNA-destabilizing proteins, KSRP and TTP. Bhattacharyya S, Kumar P, Tsuchiya M, Bhattacharyya A, Biswas R, Biochem Biophys Res Commun 2013 433 484 488 10.1016/j.bbrc.2013.03.025 23524258
41. Redefining microRNA targets. Seitz H, Curr Biol 2009 19 870 873 10.1016/j.cub.2009.03.059 19375315
42. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP, Cell 2011 146 353 358 10.1016/j.cell.2011.07.014 21802130
43. Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology. Barber SA, Bruett L, Douglass BR, Herbst DS, Zink MC, Clements JE, J Virol 2002 76 817 828 10.1128/JVI.76.2.817-828.2002 11752171 (Pubitemid 34033379)
44. Dysregulation of mitogen-activated protein kinase signaling pathways in simian immunodeficiency virus encephalitis. Barber SA, Uhrlaub JL, DeWitt JB, Tarwater PM, Zink MC, Am J Pathol 2004 164 355 362 10.1016/S0002-9440(10)63125-2 14742241 (Pubitemid 38364651)
45. Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells. Bourcier C, Griseri P, Grepin R, Bertolotto C, Mazure N, Pages G, Am J Physiol Cell Physiol 2011 301 609 C618 10.1152/ajpcell.00506.2010 21593445
46. A Lasso regression model for the construction of microRNA-target regulatory networks. Lu Y, Zhou Y, Qu W, Deng M, Zhang C, Bioinformatics 2011 27 2406 2413 10.1093/bioinformatics/btr410 21743061
47. A Least Angle Regression Model for the Prediction of Canonical and Non-Canonical miRNA-mRNA Interactions. Engelmann JC, Spang R, PLoS One 2012 7 40634 10.1371/journal.pone.0040634 22815777
48. Antagonism Pattern Detection between MicroRNA and Target Expression in Ewing's Sarcoma. Martignetti L, Laud-Duval K, Tirode F, Pierron G, Reynaud S, Barillot E, Delattre O, Zinovyev A, PLoS One 2012 7 41770 10.1371/journal.pone. 0041770 22848594
49. Regulation of tristetraprolin expression by interleukin-1 beta and dexamethasone in human pulmonary epithelial cells: roles for nuclear factor-kappa B and p38 mitogen-activated protein kinase. King EM, Kaur M, Gong W, Rider CF, Holden NS, Newton R, J Pharmacol Exp Ther 2009 330 575 585 10.1124/jpet.109.151423 19435930
50. Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment. Clement SL, Scheckel C, Stoecklin G, Lykke-Andersen J, Mol Cell Biol 2011 31 256 266 10.1128/MCB.00717-10 21078877
51. mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells. Zhang H, Taylor WR, Joseph G, Caracciolo V, Gonzales DM, Sidell N, Seli E, Blackshear PJ, Kallen CB, Arterioscler Thromb Vasc Biol 2013 33 1212 1220 10.1161/ATVBAHA.113.301496 23559629
52. Analysis of the function, expression, and subcellular distribution of human tristetraprolin. Brooks SA, Connolly JE, Diegel RJ, Fava RA, Rigby WF, Arthritis Rheum 2002 46 1362 1370 10.1002/art.10235 12115244 (Pubitemid 34525846)
53. Expression of tristetraprolin (G0S24) mRNA, a regulator of tumor necrosis factor-alpha production, in synovial tissues of patients with rheumatoid arthritis. Tsutsumi A, Suzuki E, Adachi Y, Murata H, Goto D, Kojo S, Matsumoto I, Zhong L, Nakamura H, Sumida T, J Rheumatol 2004 31 1044 1049 15170914 (Pubitemid 38715877)
54. Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor alpha, cyclooxygenase 2, and inflammatory arthritis. Phillips K, Kedersha N, Shen L, Blackshear PJ, Anderson P, Proc Natl Acad Sci U S A 2004 101 2011 2016 10.1073/pnas.0400148101 14769925 (Pubitemid 38229006)
55. Myeloid-specific tristetraprolin deficiency in mice results in extreme lipopolysaccharide sensitivity in an otherwise minimal phenotype. Qiu LQ, Stumpo DJ, Blackshear PJ, J Immunol 2012 188 5150 5159 10.4049/jimmunol.1103700 22491258
56. Left-sided cardiac valvulitis in tristetraprolin-deficient mice: the role of tumor necrosis factor alpha. Ghosh S, Hoenerhoff MJ, Clayton N, Myers P, Stumpo DJ, Maronpot RR, Blackshear PJ, Am J Pathol 2010 176 1484 1493 10.2353/ajpath.2010.090498 20093488
57. Cerebral preconditioning using cortical application of hypertonic salt solutions: upregulation of mRNAs encoding inhibitors of inflammation. Muramatsu H, Welsh FA, Kariko K, Brain Res 2006 1097 31 38 10.1016/j.brainres.2006.04.067 16725117 (Pubitemid 44043111)
58. The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis. Brennan SE, Kuwano Y, Alkharouf N, Blackshear PJ, Gorospe M, Wilson GM, Canc Res 2009 69 5168 5176 10.1158/0008-5472.CAN-08-4238
59. Similar but distinct effects of the tristetraprolin/TIS11 immediate-early proteins on cell survival. Johnson BA, Geha M, Blackwell TK, Oncogene 2000 19 1657 1664 10.1038/sj.onc.1203474 10763822 (Pubitemid 30200967)
60. MicroRNA regulation of IFN-beta protein expression: rapid and sensitive modulation of the innate immune response. Witwer KW, Sisk JM, Gama L, Clements JE, J Immunol 2010 184 2369 2376 10.4049/jimmunol.0902712 20130213
61. Real-time quantification of microRNAs by stem-loop RT-PCR. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ, Nucleic Acids Res 2005 33 179 10.1093/nar/gni178 16314309 (Pubitemid 41806407)
62. Comparison of Methods for miRNA Extraction from Plasma and Quantitative Recovery of RNA from Cerebrospinal Fluid. McAlexander MA, Phillips MJ, Witwer KW, Front Genet 2013 4 83 23720669
63. Fast and effective prediction of microRNA/target duplexes. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R, RNA 2004 10 1507 1517 10.1261/rna.5248604 15383676 (Pubitemid 39288185)
64. Most mammalian mRNAs are conserved targets of microRNAs. Friedman RC, Farh KK, Burge CB, Bartel DP, Genome Res 2009 19 92 105 18955434
65. Human MicroRNA targets. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS, PLoS Biol 2004 2 363 10.1371/journal.pbio.0020363 15502875 (Pubitemid 40280484)